|
KMID : 1149120220190020061
|
|
Journal of the Korean Society for Psoriasis
2022 Volume.19 No. 2 p.61 ~ p.64
|
|
|
A Case of Guttate Psoriasis During Infliximab Treatment in a Patient with Crohn’s Disease
|
|
Kim Jae-Yun
Eun Yun-Su
Yang Na-Gyeong
Chung Euy-Hyun
Lee Sung-Yul
|
|
|
Abstract
|
|
|
|
Infliximab (IFX) is a monoclonal antibody designed to neutralize tumor necrosis factor alpha (TNF- ) and administration of IFX is very effective in treating moderate to severe Crohn’s disease. A 25-year-old man with a history of Crohn’s disease for 2 years presented with erythematous scaly papules on his trunk and both arms since 4 months ago. He has been treated with IFX for Crohn’s disease during the last 8 months and had no previous history of psoriasis. Empirically, the lesions responded to narrowband ultraviolet B (NBUVB) therapy and topical betamethasone and calcipotriol treatment. Through skin biopsy, the patient was diagnosed with guttate psoriasis. Herein, we report a rare case of guttate psoriasis during IFX treatment.
|
|
|
KEYWORD
|
|
|
Crohn’s disease, Infliximab, Psoriasis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|